AI-powered earnings analysis with management quotes, bull/bear cases, and financial breakdowns for 400+ public companies.
Entegris looks to outpace the semiconductor scene, but can it deliver on that promise amid market uncertainties?
With revenue down 4.8%, Ford's road to recovery hits a pothole.
With a stock freeze and mixed signals, Fiserv's outlook raises eyebrows more than cheers this quarter.
Freshworks' growth fizzled out as stock takes a sharp dive amid mixed signals on CX and EX potential.
With a 5.8% stock surge, Gilead's diverse pipeline shines amid uncertainty.
Robinhood's Q4 earnings surge 26.5% but an 8.9% drop raises doubts about its prediction market potential.
Coca-Cola’s growth fizzes but can it stay sweet amidst a sour macro climate?
Despite solid growth, Klaviyo faces a rocky road as AI competition brews.
Lattice's solid revenue jump showcases its potential, but caution lingers over AI demand dynamics.
With growth investments conflicting with margins, Lyft’s earnings journey hits a pothole.
With an 8.5% stock surge, Marriott's Q4 shows they’re not just resting on their laurels—room revenue is on the rise!
Cloudflare’s unique position shines, but can its margins withstand the AI storm?
Ferrari revs into 2026 with a strong order book but faces some slippery turns ahead.
Amid a $3.9B revenue boost, S&P faces a bumpy ride with AI as a potential threat rather than a tailwind.
Spotify's earnings show AI's potential, but the competition is tuning up—will they stay in the spotlight?
Welltower's revenue soars, but can it sustain this lofty climb amidst cash flow concerns?
With disciplined growth and a 2.7% stock surge, Arch Capital proves it's weathering the reinsurance storm.
Amkor's ambitious Arizona build-out raises both hopes and concerns amid booming AI demand.
Apollo soars with a 53.6% revenue jump but faces stormy market winds ahead.
Dynatrace's AI-powered platform shines, but competition looms—can they keep their edge in FY27?
Despite a 24.6% revenue boost, Monday.com faces turbulent times ahead.
ON's earnings shine with a stock bump, but macro clouds and AI competition raise questions.
Despite decent revenue, ZoomInfo's growth fears cast a long shadow ahead—can they pivot back to the fast lane?
Biogen's stock surges despite a revenue dip—what's next for their growth ambitions?